Neogenomics Inc (NEO) 財務データ
*すべての数値は百万単位です
| 期間終了日 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Revenues | 3.77%209.25 | 201.66 | 186.67 | 190.17 | 187.80 |
| Cost Of Revenue | 2.63%112.67 | 109.78 | 105.81 | 106.83 | 107.35 |
| Gross Profit | 5.13%96.59 | 91.88 | 80.86 | 83.34 | 80.45 |
2.83%104.53 | 101.65 | 99.11 | 96.76 | 107.46 | |
| Research and Development | 8.42%9.86 | 10.76 | 9.53 | 9.18 | 8.69 |
| Operating Income/Loss | 18.73%-7.94 | -9.77 | -18.24 | -13.41 | -27.01 |
| Income/Loss From Continuing Operations Before Tax | 539.27%-8.02 | 1.83 | -17.58 | -12.41 | -26.39 |
| Income Tax Expense/Benefit | 15.29%-0.48 | -0.41 | -0.47 | -2.53 | 0.74 |
437.18%-7.55 | 2.24 | -17.11 | -9.88 | -27.13 | |
| Attributable To Parent | 437.18%-7.55 | 2.24 | -17.11 | -9.88 | -27.13 |
| Basic Average Shares | 0.80%128.59 | 129.63 | 129.17 | 0.18 | 128.42 |
| Diluted Average Shares | 1.72%128.59 | 130.83 | 129.17 | 0.18 | 128.42 |